BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5721657)

  • 1. Passive hemagglutination studies with snake venom and antivenin.
    Boche RD; Russell FE
    Toxicon; 1968 Oct; 6(2):125-30. PubMed ID: 5721657
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous antivenin in clinical snake venom poisoning. A preliminary report.
    PARRISH HM
    Mo Med; 1963 Mar; 60():240-4. PubMed ID: 13941591
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies of cross protection between sera and venoms of the most common species of Mexican snakes].
    Pérez de la Mora S; Pérez-Miravete A; García Pérez G
    Rev Invest Salud Publica; 1972; 32(3-4):145-57. PubMed ID: 4208266
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).
    Pradhan S; Kumar S; Singh D; Sood RC; Sehgal R
    Biologicals; 2007 Jun; 35(3):155-60. PubMed ID: 17088076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous antivenin in neutralization of North American coral snake venom.
    KEEGAN HL; WHITTEMORE FW; FLANIGAN JF
    Public Health Rep (1896); 1961 Jun; 76(6):540-2. PubMed ID: 13752144
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative studies on the effectiveness of an antivenin and its fractions.
    Timmerman WF; Russell FE
    Toxicon; 1969 May; 6(4):311-4. PubMed ID: 5805127
    [No Abstract]   [Full Text] [Related]  

  • 7. Reverse passive hemagglutination tests for rapid diagnosis of snake envenomation.
    Kittigul L; Ratanabanangkoon K
    J Immunoassay; 1993 Sep; 14(3):105-27. PubMed ID: 8354715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyvalent antivenin in treatment of experimental snake venom poisoning.
    MINTON SA
    Am J Trop Med Hyg; 1954 Nov; 3(6):1077-82. PubMed ID: 13207562
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological properties of antivenins. I. Bivalent Cerastes cerastes and Cerastes vipera antivenin.
    Hassan F; El-Hawary MF
    Am J Trop Med Hyg; 1975 Nov; 24(6 Pt 1):1031-4. PubMed ID: 812369
    [No Abstract]   [Full Text] [Related]  

  • 10. Snake and spider antivenin: risks and benefits of therapy.
    Weisman RS; Lizarralde SS; Thompson V
    J Fla Med Assoc; 1996 Mar; 83(3):192-5. PubMed ID: 8920051
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paraspecificity of antivenins: example of severe envenomation by the Sahara horned viper (Cerastes cerastes) treated with non-specific antivenin].
    Aissaoui Y; Kichna H; Boughalem M; Drissi Kamili N
    Med Sante Trop; 2013; 23(1):100-3. PubMed ID: 23695188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice.
    Consroe P; Egen NB; Russell FE; Gerrish K; Smith DC; Sidki A; Landon JT
    Am J Trop Med Hyg; 1995 Nov; 53(5):507-10. PubMed ID: 7485708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of snake venoms in tissue fluids.
    Coulter AR; Sutherland SK; Broad AJ
    J Immunol Methods; 1974 Mar; 4(2):297-300. PubMed ID: 4857069
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation and standardization of toxoid from the venom of Trimeresurus flavoviridis (Habu).
    Kondo S; Sadahiro S; Yamauchi K; Kondo H; Murata R
    Jpn J Med Sci Biol; 1971 Oct; 24(5):281-94. PubMed ID: 5316782
    [No Abstract]   [Full Text] [Related]  

  • 15. [Snake venoms. 2. The chemical constitution of snake venoms and immunity against venoms].
    Boquet P
    Toxicon; 1966 Apr; 3(4):243-79. PubMed ID: 5332593
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of antivenin prepared from goat serum.
    Russell FE; Timmerman WF; Meadows PE
    Toxicon; 1970 May; 8(1):63-5. PubMed ID: 5465748
    [No Abstract]   [Full Text] [Related]  

  • 17. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and toxological problems in poisonous snake bites].
    Scholer H; Wüthrich W
    Schweiz Med Wochenschr; 1970 Oct; 100(42):1761-6. PubMed ID: 5480546
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the immunogenic properties of photooxidized Formosan snake venoms, with special reference to a trial preparation of polyvalent antivenin using photooxidized multiple venom antigens--second report.
    Huang CT; Huang JS; Ling KH; Lin SY
    Taiwan Yi Xue Hui Za Zhi; 1973 Apr; 72(4):208-17. PubMed ID: 4515138
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects on phospholipase A2 and antivenin activity of melanin extracted from Thea sinensis Linn.
    Hung YC; Sava V; Hong MY; Huang GS
    Life Sci; 2004 Mar; 74(16):2037-47. PubMed ID: 14967198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.